×

EBUS and Molecular Testing in Lung Cancer


Evaluated by: David B. Kaminsky, M.D., FIAC, August 15, 2017
Original release date: August 15, 2017
Access to this course expires on: January 14, 2020
CME/SAM 1.0

Faculty: Sara E. Monaco, M.D.

Learning Objectives:
  • Understand the role of EBUS-TBNA and EUS-FNA in the diagnosis of mediastinal and lung lesions.
  • Recognize the key cytomorphological findings in common and uncommon entities seen in the lung/mediastinum.
  • Formulate a differential diagnosis based on the cytomorphology of different entities, which will impact the ancillary studies requested and create an awareness of pitfalls to avoid.

To earn CME and SAM credit, all learners must take a content-based exam and achieve a minimum score of 80%. If learners do not achieve a passing score of 80%, they have the option to retake the exam. After you pass the test and complete the evaluation, your certificate of completion will be available to view and print by clicking here.
blog comments powered by Disqus